Published On: Wed, Oct 19th, 2016

McKesson Corporation (NYSE:MCK) Latest Broker Coverage


A number of investment brokers have recently updated their price targets on shares of McKesson Corporation (NYSE:MCK).

Most recent broker ratings

10/06/2016 – UBS began new coverage on McKesson Corporation giving the company a “neutral” rating. They now have a USD 182 price target on the stock.

09/26/2016 – McKesson Corporation had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 183 price target on the stock.

09/19/2016 – McKesson Corporation had its “hold” rating reiterated by analysts at Argus.

09/16/2016 – McKesson Corporation was downgraded to “neutral” by analysts at Goldman Sachs. They now have a USD 189 price target on the stock.

09/15/2016 – McKesson Corporation was upgraded to “strong buy” by analysts at Vetr Inc..

09/01/2016 – McKesson Corporation had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 230 price target on the stock.

07/14/2016 – McKesson Corporation had its “buy” rating reiterated by analysts at Deutsche Bank.

07/05/2016 – McKesson Corporation had its “market perform” rating reiterated by analysts at Avondale Partners. They now have a USD 197 price target on the stock.

06/29/2016 – McKesson Corporation had its “outperform” rating reiterated by analysts at Robert W. Baird. They now have a USD 220 price target on the stock.

06/28/2016 – McKesson Corporation had its “outperform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 210 price target on the stock.

06/07/2016 – McKesson Corporation had its “neutral” rating reiterated by analysts at Bank of America Merrill Lynch. They now have a USD 190 price target on the stock.

04/26/2016 – McKesson Corporation was downgraded to “hold” by analysts at Standpoint Research.

03/16/2016 – Credit Suisse began new coverage on McKesson Corporation giving the company a “neutral” rating. They now have a USD 175 price target on the stock.

03/15/2016 – McKesson Corporation was downgraded to “market perform” by analysts at Cowen. They now have a USD 173 price target on the stock.

01/15/2016 – McKesson Corporation had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 211 price target on the stock.

The share price of McKesson Corporation (NYSE:MCK) was up +0.90% during the last day of trading, with a day high of 163.12. 743683 shares were traded during the last session.

The stock’s 50 day moving average is 169.92 and its 200 day moving average is 179.59. The stock’s market capitalization is 36.59B. McKesson Corporation has a 52-week low of 148.29 and a 52-week high of 202.20.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.